Ginseng-derived nanoparticles alleviate inflammatory bowel disease via the TLR4/MAPK and p62/Nrf2/Keap1 pathways.
Yang S, Li W, Bai X, Di Nunzio G, Fan L, Zhao Y, Ren L, Zhao R, Bian S, Liu M, Wei Y, Zhao D, Wang J.
Yang S, et al. Among authors: zhao y, zhao d, zhao r.
J Nanobiotechnology. 2024 Feb 1;22(1):48. doi: 10.1186/s12951-024-02313-x.
J Nanobiotechnology. 2024.
PMID: 38302938
Free PMC article.